Development of heart failure is known to be associated with changes in energy substrate metabolism. Information on the changes in energy substrate metabolism that occur in heart failure is limited and results vary depending on the methods employed. Our aim is to characterize the changes in energy substrate metabolism associated with pressure overload and ischaemia-reperfusion (I/R) injury.
Introduction
Coronary artery disease and hypertension are prevailing causes of heart failure. 1, 2 Metabolic perturbations in the heart that occur as a result of coronary artery disease and/or hypertension can play a key role in the pathogenesis of heart failure. 3, 4 Other important mechanisms involved in the development of pathological hypertrophy and heart failure include abnormal signal transduction 5 , mitochondrial dysfunction 3 , and disrupted intracellular Ca 2+ handling. 6 Most of these mechanisms affect utilization of energy substrates, which are required to generate ATP primarily for contraction. As heart failure progresses, cardiac energetic status (as measured by ATP and phosphocreatine content) is altered considerably. 3,7 -9 However, specific details about the particular energy-generating pathways that underlie these reductions in high-energy phosphate levels are less clear. In human heart failure, there is a reversal to the foetal energy metabolic profile, resulting in a shift from fatty acid utilization towards glucose utilization. 3,10 -12 The available data from animal models of heart failure are in general agreement with the findings in human heart failure. For example, in vivo measurements showed increased glucose oxidation and decreased fatty acid oxidation in canine pacing-induced heart failure. 13 Similarly, ex vivo and in vivo metabolic rates in the pressure-overloaded rat and the spontaneously hypertensive rat (SHR) model showed early and substantial decrease in fatty acid oxidation with a relatively greater reliance on glucose oxidation. 14 -16 Murine models of heart failure are of considerable utility because of the multitude of transgenic and knockout strains available. This variety of gene-targeted murine models has the potential to provide considerable insight into the mechanism and the development of new therapies for heart failure. Emerging data suggest that cardiac metabolism is altered in murine models of heart disease. 17, 18 In this study, we sought to characterize: (i) changes in energy substrate metabolism associated with pressure overload-induced heart failure and (ii) possible alterations in related regulatory pathways that may govern these changes. To describe metabolic alterations due to pressure overload in wild-type C57Bl/6 mice, we utilized an isolated working heart preparation, in which hearts were perfused at physiological preload (11.5 mmHg) and afterload (80 mmHg), and we also investigated how pressure-overloaded hearts respond to ischaemiareperfusion (I/R) injury.
Methods
See Supplementary material online, Methods for detailed methodology.
Experimental animals
C57/Bl6 male mice (n ¼ 54) weighing 27.5 + 0.3 g were subjected to a transverse aortic constriction (TAC) or a sham procedure and, 6 weeks later, were subjected to an ex-vivo aerobic or I/R protocol (described below). All animals received care according to the standards of the Canadian Council of Animal Care, and all procedures were approved by the University of Alberta Health Sciences Animal Welfare Committee. All procedures were compliant with the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication, 8th edition, 2011; University of Alberta assurance number: A5070-01).
Pressure overload
Young (8-to 9-week-old) male mice were subjected to pressure overload as previously described. 19, 20 Briefly, mice were anaesthetized with 1.5 -2%
isoflurane/oxygen and the surgical plane of anaesthesia was monitored by the lack of response to toe-pinching. The aortic arch was accessed via a left thoracotomy, and the thoracic aorta at the arch was surgically constricted against a 27-gauge needle to generate a trans-stenotic pressure gradient of 50 -60 mmHg. The sham animals underwent the same procedure without aortic banding. Animals were studied at 5 -6 weeks following the TAC or sham operations.
Echocardiography and tissue Doppler imaging
Mice were anaesthetized with 1% isofluorane/oxygen administered through inhalation. Transthoracic echocardiography and tissue Doppler imaging were performed non-invasively to assess systolic and diastolic function, as described previously, using a Vevo 770 high-resolution imaging system equipped with a 30-MHz transducer (RMV-707B; VisualSonics). 21 
Isolated working heart perfusions
Hearts were excised from mice after induction of anaesthesia with sodium pentobarbital (400 mg/kg, i.p.) and administration of heparin (100 units, i.p.), and the aorta and left atrium were rapidly cannulated, as described previously. 22, 23 Hearts were initially perfused at an 11.5 mmHg left atrial (LA) preload, and a 50 mmHg aortic afterload. Within 3 -5 min the aortic afterload was increased and maintained at 80 mmHg. The hearts were subjected to either aerobic perfusion for 45 min or to an I/R protocol where hearts were subjected to 45 min of aerobic perfusion, followed by 15 min of global ischaemia (378C) and 30 min of aerobic reperfusion.
Measurement of mechanical function ex vivo
Isolated working heart perfusions were performed at atrial preload of 11.5 mmHg and a physiological aortic afterload of 80 mmHg. 
Assay for glycogen content and glucose uptake
Glycogen from frozen heart powder was extracted and hydrolyzed to glucose, as previously described. 25 The amount of glucose was measured using a Sigma glucose kit (Sigma-Aldrich). Aliquots from the above hydrolyzed glycogen were used to measure incorporation of [ 3 H/ 14 C]glucose into glycogen (glycogen synthesis). The rates of glucose uptake were calculated as the sum of rates of glycolysis and glycogen synthesis, and are expressed as mmol min 21 g 21 dry weight.
Immunoblot analysis
Immunoblot analyses were performed as described previously. 26 Frozen ventricular tissue was homogenized to extract protein. After quantification by a Bradford protein assay kit (Bio-Rad), protein samples were subjected to SDS -polyacrylamide gel electrophoresis and transferred onto a nitrocellulose membrane. Following the pretreatment, membranes were probed with the appropriate antibodies. Immunoblots were visualized using an enhanced chemiluminescence western blot detection kit Pressure-overload reduces myocardial glucose oxidation (Perkin Elmer) and quantified with Image J software (U.S. National Institutes of Health). Membrane fractionation was performed for GLUT-4 immunoblotting.
Determination of malonyl CoA levels
Malonyl CoA levels 26 and PCr/ATP ratio 27 were measured in homogenized ventricular tissue (previously frozen) by high-performance liquid chromatography.
Statistics
All values are expressed as the mean + the standard error of the mean (SEM) for n independent observations. Levels of significance were tested using Student's t-test or by ANOVA and Bonferroni post hoc tests with selected pairs for multiple comparisons. Differences were judged to be significant when P , 0.05. Statistical calculations were performed using GraphPad InStat (v.3.01). ( Figure 1C ). Significant decreases in ejection fraction (EF) ( Figure 1D ) and velocity of circumferential shortening (VCF C ) in the TAC hearts compared with the sham hearts ( Figure 1E ) indicated systolic dysfunction. To assess diastolic function, mitral and tissue Doppler measurements and LA size were evaluated. Representative examples of transmitral flow and tissue Doppler are shown in Figure 1F . Pressure-overload changes in diastolic function revealed increased LA size, reduced E ′ /A ′ ratio, increased E/A ratio, and shortened deceleration time in the TAC hearts ( Figure 1G-J) . These results show clear evidence of LV hypertrophy and systolic and diastolic dysfunction in response to TAC-induced pressure-overload.
Isolated working heart function
Heart weight (dry) was significantly higher (+71%) in the TAC group confirming pressure-overload hypertrophy (Figure 2A and B) . Peak systolic pressure was significantly lower in TAC hearts compared with sham hearts ( Figure 2C ), whereas end-diastolic pressure was similar resulting in reduced developed pressure (DevP) in aortas of the TAC hearts ( Figure 2C and D). Since hydrodynamic resistance is nearly constant in the working heart perfusion system, decreases in DevP invariably result in a decreased flow. All flow parameters were significantly reduced in the TAC hearts compared with sham hearts. Coronary flow (CF), aortic flow (AF), and CO decreased by 39, 69, and 58%, respectively ( Figure 2E and F ).
Pressure-overload-induced reduction in glucose and lactate oxidation
Metabolic rates of glucose, lactate, palmitate, and triacylglycerol oxidation were evaluated in the sham and TAC hearts. These measurements were done in pairs: glycolysis ( 3 H) with glucose oxidation ( 14 C), palmitate oxidation ( 3 H) with lactate oxidation ( 14 C), and TG was measured separately. Glucose metabolism was suppressed overall in hearts from TAC mice: rates of glucose oxidation decreased by 66% while rates of glycolysis trended to be lower (228%, P ¼ 0.07) ( Figure 3A) . Similarly, the rate of lactate oxidation was significantly lower (by 33%) whereas the rate of palmitate oxidation was unchanged ( Figure 3B) . The TG content decreased between 0 and 45 min of perfusion time ( Figure 3C ) and derived the rate of TG oxidation was lower in the TAC hearts ( Figure 3D ). These decreases in the energy substrate utilization in the TAC hearts resulted in an overall energy-compromised state of the hearts as illustrated by a decrease in the phosphocreatine -ATP ratio from 1.69 + 0.04 (n ¼ 6) in the sham hearts to 1.27 + 0.11 (n ¼ 6) in the TAC hearts (P ¼ 0.01). The decreases were also accompanied by a reduction in LV power by 80% ( Figure 3E) . Decreases in the rates of glucose and lactate oxidation in hearts from the TAC mice raised the question as to whether the glycogen content and synthesis were affected by pressure-overload-induced heart disease. The glycogen content increased from 0 to 45 min in both sham and TAC hearts. However, in TAC hearts, the increase was smaller ( Figure 3F ) and the derived glycogen synthesis ( Figure 3G ) and glucose uptake ( Figure 3H) were reduced.
Pressure-overload-induced changes in regulatory pathways
Given such marked changes in glucose metabolism and glycogen synthesis, we decided to assess possible alterations in: (i) the insulin pathway (Akt phosphorylation), (ii) the conversion of pyruvate to acetyl CoA [pyruvate dehydrogenase (PDH) phosphorylation and pyruvate dehydrogenase kinase isozyme 4 (PDK4) expression], (iii) the AMP-activated protein kinase (AMPK) pathway, (iv) acetyl CoA carboxylase (ACC) phosphorylation, malonyl CoA decarboxylase (MCD) expression, and malonyl CoA levels, (v) peroxisome proliferator-activated receptor gamma coactivator 1-a (PGC-1a) expression, and (vi) glucose transporter type 4 (GLUT4) levels. In the TAC hearts, Akt phosphorylation at both Thr308 and Ser473 residues was significantly down-regulated compared with sham hearts (by 58 and 54%, respectively) ( Figure 4A ). Neither PDH phosphorylation nor PDK4 expression was appreciably affected ( Figure 4B) . However, there were considerable alterations in the AMPK pathway. In TAC mice, myocardial AMPK phosphorylation increased by 150% ( Figure 4C) , which was accompanied by an increase in ACC phosphorylation by 120% (D). While there was a tendency for a decreased MCD expression (223%, P ¼ 0.08), malonyl CoA levels, which are controlled by ACC and MCD, were significantly lower ( Figure 4E) . PGC-1a expression levels were almost double in TAC hearts (P ¼ 0.04) ( Figure 4F ). Reduction in derived glucose uptake ( Figure 3H ) due to TAC was confirmed by the measurement of GLUT4 levels in the plasma membrane. The GLUT4 level in membrane (GLUT4-PM) of TAC hearts was decreased (P ¼ 0.04) without changes in the cytoplasmic GLUT4 (GLUT4-CP) levels ( Figure 4G ).
I/R injury reduces glucose oxidation and increases TG oxidation
Co-existence of coronary artery disease in patients with pressure-overload-induced heart failure is a common clinical scenario. Indeed, heart failure is multifactorial with coronary artery disease and hypertension being the most common causes of heart failure. 1 -3,28,29 To evaluate how pressure overload affects cardiac response to I/R, we subjected sham and TAC hearts to I/R protocol. While TAC hearts had baseline LV power (average LV power from 0 to 45 min) 80% lower than sham, following 15 min of global ischaemia, cardiac power in both groups substantially diminished ( Figure 5A ). To compare severity of I/R injury between groups, average time courses of LV power for both groups were normalized to respective baselines ( Figure 5B ). In the sham group, LV power initially recovered to 44% of baseline at 10 min post-reperfusion and then decreased to 36% at 30 min of the reperfusion period. In contrast, in the TAC hearts, cardiac power recovered to about 23% of pre-ischaemic level and stayed unchanged afterwards ( Figure 5B ). Lactate oxidation, palmitate oxidation, and glycolysis were unchanged by I/R. However, glucose oxidation rates showed a significant reduction in TAC hearts, coupled with an increased TG oxidation in both groups ( Figure 5C ). Figure 4 Characterization of pressure-overload induced changes in metabolic regulatory pathways. Changes in the phosphorylation levels of Akt (Thr308, left and Ser473, right) (A), and PDH (left) and expression levels of PDK4 (right) (B). Changes in phosphorylation levels of AMPK (C) and ACC (D) and changes in MCD (left) and malonyl CoA levels right) (E). Alterations in PGC-1a levels (F) and GLUT-4 levels in the plasma membrane (PM, left) and cytoplasm (CP, right) (G). PDH, pyruvate dehydrogenase; PDK4, pyruvate dehydrogenase; AMPK, AMP-activated protein kinase; ACC, acetyl CoA carboxylase; MCD, malonyl CoA decarboxylase, and PGC-1a, peroxisome proliferator-activated receptor g co-activator 1-a. n ¼ 7; white bars (sham group) and n ¼ 7; grey bars (TAC group). *P , 0.05 compared with the Sham group.
Pressure-overload reduces myocardial glucose oxidation 3.5 Changes in acetyl CoA production due to pressure overload and I/R injury To gain further insight into the changes in oxidation rates of multiple substrates in the TAC hearts, we recalculated oxidation rates of all energy substrates to the equivalent amounts of acetyl CoA that is utilized in TCA cycle or acetyl CoA production ( Figure 6A ). Under baseline aerobic conditions, overall acetyl CoA production was decreased by 43% in TAC hearts compared with sham hearts. However, the overall reduction in the rate of acetyl CoA production (Figures 6A) was not in proportion with the decrease in LV power ( Figures 3E  and 5A ), which declined considerably more than the rate of the total acetyl-CoA production, suggesting a reduction in overall cardiac efficiency. Expressing cardiac efficiency as LV work per acetyl CoA (power divided by acetyl CoA production) reveals an overall reduction in cardiac efficiency of 66% for the TAC hearts compared with the sham hearts ( Figure 6B, baseline) . The decrease in acetyl CoA production was not uniform across energy substrates: glucose oxidation decreased, and lactate oxidation was reduced to a lesser extent ( Figure 6A ), whereas oxidation of fatty acids was largely unchanged ( Figure 6C) . As a result, sham hearts produced more acetyl CoA from glucose and lactate oxidation than from fatty acid and TG oxidation, whereas TAC hearts displayed the reverse situation. This demonstrated a shift in preferences for oxidative substrate from carbohydrates to fatty acids, which is clearly illustrated when acetyl CoA from each energy substrate is expressed as a per cent of the total acetyl CoA production ( Figure 6D) . In response to I/R, the total rate of acetyl CoA production was unchanged in sham hearts ( Figure 6A ), which in a setting of reduced LV power ( Figure 5B) resulted in a lower cardiac efficiency. However, the composition of the acetyl CoA pool was altered, with a relative reduction in glucose oxidation and a significant increase in TG oxidation ( Figure 6C ). In contrast, I/R in the TAC hearts exacerbated these changes and increased the total rate of acetyl CoA production ( Figure 6A ) coupled with a reduction in cardiac power and compromised cardiac efficiency ( Figures 5B and 6B) . The increase in the total rate of acetyl CoA production occurred due to an increase in TG oxidation ( Figure 6C and D) . These data show that pressure-overloaded heart failure is associated with reduced cardiac efficiency and increased susceptibility to I/R injury probably driven by the reduction in glucose oxidation and increase in TG oxidation.
Discussion
Pressure-overload, resulting from hypertension or aortic valvular stenosis, and coronary artery disease remain the most common causes of heart failure. 1, 2, 28, 29 Metabolic defects can play a critical role in the initiation and progression of heart failure and metabolic modulators have been proposed as a potential therapy for heart failure. 3, 4, 30 As predicted, pressure-overload in our murine model resulted in LV hypertrophy and LV dilation, and both LV systolic and LV diastolic dysfunction. Importantly, energy metabolic profiling of the pressure-overloaded hearts revealed a clear shift from glucose to fatty acid and TG oxidation in hypertrophied mouse hearts. In response to I/R, pressure-overloaded hearts show an exacerbation of these energy metabolic changes, with a further lowering of carbohydrate oxidation, an increase in TG oxidation, and a reduced cardiac efficiency. Our findings appear to be discordant with recent findings which demonstrated enhanced glucose and reduced fatty acid oxidation in pressure-overload-induced heart disease. 17, 18 However, although the recent study by Riehle et al. 17 only measured fatty acid oxidation in tissue homogenates following pressure overload hypertrophy in mice hearts, they did observe an actual increase in fatty acid oxidation rates in the wild-type hypertrophied mice hearts. Also of interest is that the study of Kolwicz et al. 18 demonstrated that in wild-type mice, pressure overload hypertrophy resulted in a much more dramatic increase in glycolysis than glucose oxidation in the heart. Combined, these data are consistent with our data showing a selective impairment in glucose oxidation compared with other metabolic pathways. The Kolwicz et al. 18 study also used hypertrophied mice heart with a very mild cardiac dysfunction. Comparison among studies is difficult, however, due to differences in animal models used with different degrees of heart disease, concentration of substrates, degree of afterload, and variation in the inclusion of insulin. Two potential causes for the reduced rates of carbohydrate (glucose and lactate) oxidation in a setting of preserved fatty acid (palmitate) oxidation are: (i) insufficient availability of glucose or (ii) impaired conversion of pyruvate to acetyl CoA. Insufficient availability Pressure-overload reduces myocardial glucose oxidation of glucose can occur due to down-regulation of glucose transporters, which is consistent with reduced Akt phosphorylation and reduced levels of plasma-membrane GLUT4 in the TAC hearts. The decline in glycogen synthesis is also consistent with (i) down-regulation of the Akt signalling pathway and (ii) reduced glucose uptake due to reduced plasma-membrane GLUT4 levels; therefore, the reduced glycogen synthesis is likely reflective of an insulin-resistant state. 31 This result is in agreement with previous findings showing that lack of insulin signalling in the heart accelerates the transition to a more decompensated state during cardiac pressure-overload, 32 while overexpression of the GLUT1 transporter prevents pressure-overloadinduced heart failure. 33 The conversion of pyruvate to acetyl CoA occurs via the PDH complex. Both phosphorylation of PDK4, the primary determinant of PDH activity, and expression of PDH were unaffected in the TAC hearts, suggesting that pyruvate conversion into acetyl CoA was not impaired. These molecular changes are clearly distinct from agonist-mediated hypertrophy and diastolic dysfunction in which glucose oxidation is also dramatically lowered, but with increased PDK4 expression and phosphorylation of PDH.
22
Our results illustrate a greater susceptibility to myocardial I/R injury in pressure-overloaded hearts, a relatively common clinical scenario as hypertension and coronary disease often co-exist and are common causes of heart failure. the poor performance of the pressure-overload hearts in response to I/R injury. The reduction in the glycogen content in pressure-overload hearts also likely contributed to the increase in susceptibility to I/R injury. 37 While reduced carbohydrate oxidation is expected to lead to a compensatory increase in fatty acid oxidation (based on the principles of the Randle Cycle), we also detected substantial changes in the AMPK pathway in TAC hearts, which resulted in decreased malonyl CoA levels. Increased phosphorylation of AMPK likely resulted in increased phosphorylation and inhibition of ACC, thereby reducing malonyl CoA synthesis. 4, 38 Malonyl CoA, an endogenous inhibitor of carnitine palmitoyltransferase 1 (CPT1), decreases fatty acid b-oxidation. 4, 39 In support of this, increased myocardial fatty acid uptake and b-oxidation during high workloads is accompanied by a decrease in myocardial malonyl CoA content in pigs 40 and rats. 41 As a result, the decreased malonyl CoA levels observed in TAC hearts may account for the switch to fatty acid oxidation in the TAC hearts compared with the sham hearts.
In this study, we describe a comprehensive assessment of changes in energy metabolic rates for glucose, lactate, fatty acids, and TG in a murine pressure-overload heart disease model. In addition to a large decrease in cardiac power, pressure-overloaded hearts also had a disproportionally large increase in oxidation of TG during reperfusion, resulting in dramatic increase in the share of acetyl CoA generated from TG oxidation. We have also shown that agonist-mediated hypertrophy and diastolic dysfunction in mice also reduces myocardial glucose and lactate oxidation with no impact on fatty acid oxidation. 22 In contrast, pressure-overload introduced by TAC in rats results in early and substantial inhibition of fatty acid oxidation (with either no change or a non-significant reduction in glucose oxidation) in association with reduced cardiac power and performance. 14, 15 Similarly, in the SHR model characterized by concentric hypertrophy and diastolic dysfunction (with preserved systolic function), a preference for glucose metabolism and a shift away from predominantly fatty acid oxidative metabolism occurs. 16 In vivo assessments of metabolic rates in the pacing-induced heart failure in dogs also showed changes similar to humans in vivo data, 3, 12, 42 with a shift from fatty acid utilization towards glucose utilization. 10, 13 These differences between the metabolic changes in animal models of heart failure must be taken into consideration when results of genetargeted murine models of metabolism and heart failure are studied. The differences in responses of metabolic rates to heart failure could partially be attributed to the differences in the basal substrate preferences. For example, in mouse heart, GOX is much more a contributor to energy metabolism than in rat heart, whereas FOX contribution is relatively low in mouse heart compared with rat. 14, 15, 22, 23 Enhancing glucose oxidation may prove to be beneficial in heart failure as an attempt to use an 'oxygen-efficient' energy substrate for ATP synthesis. Dichloroacetate, a compound that enhances glucose oxidation, increases energy reserves and improves cardiac function and survival in heart failure in SHR. 43 Similarly, stimulating glucose oxidation via targeting either PDH or MCD decreases an infarct size in murine models, validating the concept that optimizing myocardial metabolism may be an effective therapy for ischaemic heart disease.
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